IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $660,225 | -34.2% | 18,473 | -30.5% | 0.00% | -33.3% |
Q4 2022 | $1,003,889 | -13.2% | 26,579 | +1.7% | 0.00% | 0.0% |
Q3 2022 | $1,156,000 | +14.6% | 26,127 | -4.1% | 0.00% | 0.0% |
Q2 2022 | $1,009,000 | +48.4% | 27,237 | +48.3% | 0.00% | +50.0% |
Q1 2022 | $680,000 | +427.1% | 18,362 | +331.7% | 0.00% | – |
Q4 2021 | $129,000 | -9.8% | 4,253 | 0.0% | 0.00% | – |
Q3 2021 | $143,000 | -12.3% | 4,253 | +4.0% | 0.00% | – |
Q2 2021 | $163,000 | -62.2% | 4,090 | -46.3% | 0.00% | -100.0% |
Q4 2020 | $431,000 | +19.4% | 7,622 | +0.2% | 0.00% | 0.0% |
Q3 2020 | $361,000 | -22.0% | 7,604 | -3.2% | 0.00% | 0.0% |
Q2 2020 | $463,000 | -83.2% | 7,856 | -86.5% | 0.00% | -87.5% |
Q1 2020 | $2,753,000 | +405.1% | 58,235 | +545.8% | 0.01% | +700.0% |
Q4 2019 | $545,000 | +429.1% | 9,018 | +424.6% | 0.00% | – |
Q3 2019 | $103,000 | -98.8% | 1,719 | -98.7% | 0.00% | -100.0% |
Q2 2019 | $8,408,000 | -61.3% | 130,823 | -51.2% | 0.02% | -63.0% |
Q1 2019 | $21,744,000 | +198.6% | 267,878 | +98.9% | 0.05% | +170.0% |
Q4 2018 | $7,282,000 | +710.0% | 134,700 | +662.6% | 0.02% | +566.7% |
Q2 2017 | $899,000 | -64.1% | 17,664 | -71.7% | 0.00% | -57.1% |
Q1 2017 | $2,507,000 | +162.0% | 62,358 | +211.8% | 0.01% | +133.3% |
Q4 2016 | $957,000 | +30.6% | 20,000 | 0.0% | 0.00% | +50.0% |
Q3 2016 | $733,000 | +65.8% | 20,000 | +5.5% | 0.00% | +100.0% |
Q2 2016 | $442,000 | +44100.0% | 18,966 | +379220.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |